Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

Jenkins BG, Sanchez-Pernaute R, Brownell AL, Chen YC, Isacson O.

J Neurosci. 2004 Oct 27;24(43):9553-60.

2.

[Functional imaging in movement disorders].

Swiat M, Opala G, Jasińska-Myga B.

Neurol Neurochir Pol. 2006 Jan-Feb;40(1):42-50. Review. Polish.

PMID:
16463221
3.

Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.

Howell LL, Murnane KS.

Ann N Y Acad Sci. 2008 Oct;1141:176-94. doi: 10.1196/annals.1441.023. Review.

4.

Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging.

Sánchez-Pernaute R, Brownell AL, Jenkins BG, Isacson O.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):251-6. Review.

PMID:
15979668
5.

[Receptor mapping in living human beings by means of positron emission tomography].

Gjedde A.

Ugeskr Laeger. 2001 Sep 17;163(38):5199-205. Review. Danish.

PMID:
11577527
6.

Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.

Jenkins BG.

Neuroimage. 2012 Aug 15;62(2):1072-85. doi: 10.1016/j.neuroimage.2012.03.075. Epub 2012 Apr 1. Review.

7.

Brain imaging in nonhuman primates: insights into drug addiction.

Nader MA, Czoty PW.

ILAR J. 2008;49(1):89-102. Review.

PMID:
18172336
8.

[Neuroimaging and cocaine: mapping dependence?].

Lambert G, Karila L, Lowenstein W.

Presse Med. 2008 Apr;37(4 Pt 2):679-88. doi: 10.1016/j.lpm.2007.08.014. Epub 2008 Mar 4. Review. French.

PMID:
18164583
9.

PET studies in the MPTP model of Parkinson's disease.

Doudet DJ.

Adv Neurol. 2001;86:187-95. Review. No abstract available.

PMID:
11553977

Supplemental Content

Support Center